MARKET

ALPMF

ALPMF

Astellas Pharma
OTCPK
12.20
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
12.20
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
67.86
52 WEEK LOW
10.78
MARKET CAP
21.85B
P/E (TTM)
26.01
1D
5D
1M
3M
1Y
5Y
1D
Upstream Bio: Maintaining Buy Rating On Verekitug Success In Phase 2 CRSwNP Study
Seeking Alpha · 12h ago
Taysha Gene Therapies upgraded at Goldman Sachs on advancing Rett syndrome asset
Seeking Alpha · 1d ago
Weekly Report: what happened at ALPMF last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at ALPMF last week (1117-1121)?
Weekly Report · 11/24 10:00
Merck Keytruda formulations approved in U.S. for bladder cancer
Seeking Alpha · 11/21 17:42
Weekly Report: what happened at ALPMF last week (1110-1114)?
Weekly Report · 11/17 09:59
This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power
Benzinga · 11/12 18:36
Weekly Report: what happened at ALPMF last week (1103-1107)?
Weekly Report · 11/10 09:58
More
About ALPMF
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Webull offers Astellas Pharma Inc stock information, including OTCPK: ALPMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPMF stock methods without spending real money on the virtual paper trading platform.